In tumor cells, the EGFR signaling mainly activates downstream RAS/MAPK, PI3K/ Akt, PLCγ/PKC and JAK/STAT3 signaling pathways, promoting cancer cell growth and metastasis 19. Here, EGFR is linked to cancer.